Effectiveness of Hormonal Intrauterine Device in Treating PCS Compared to Oral Progestin

计划入组 104 人 · 首次发布于 2021 年 9 月 20 日

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

计划入组 41 人 · 首次发布于 2018 年 6 月 26 日

TQB2450 Plus Progestin for Fertility-sparing Treatment in MMRd EC

计划入组 10 人 · 首次发布于 2025 年 4 月 6 日

Conjugated estrogens/progestin

Dienogest(Natazia, Visanne)

C₂₀H₂₅NO₂ · Rx

Progestin controlled release(Medincell)

Oral-B Laboratories

United States

Philips Oral Healthcare

United States

ORAL RECONSTRUCTION FOUNDATION

United States

Hormonal Contraceptives and HRT Linked to Increased Cardiovascular Risks in Women

Bayer Launches Phase III Trial Testing Mirena IUD for Precancerous Uterine Condition with No Approved Treatments

Ingenus Pharmaceuticals Launches First Generic Version of Premarin Tablets After FDA Approval